🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, claiming the firms concealed safety concerns that the pain reliever presented to children's neurological development.

The court filing arrives a month after President Donald Trump promoted an unproven link between using acetaminophen - also known as paracetamol - while pregnant and autism spectrum disorder in offspring.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by gaining financially from discomfort and pushing pills ignoring the dangers."

The company says there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These corporations deceived for years, deliberately risking countless individuals to line their pockets," Paxton, from the Republican party, said.

The manufacturer commented that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its official site, the company also stated it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between taking acetaminophen and autism spectrum disorder."

Associations acting on behalf of doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in Tylenol - is among limited choices for expectant mothers to address discomfort and fever, which can create serious health risks if ignored.

"In multiple decades of investigation on the use of acetaminophen in gestation, no reliable research has definitively established that the usage of acetaminophen in any stage of pregnancy leads to brain development issues in young ones," the association commented.

The lawsuit references recent announcements from the Trump administration in asserting the drug is reportedly hazardous.

Last month, the former president generated worry from health experts when he advised expectant mothers to "resist strongly" not to consume Tylenol when unwell.

Federal regulators then released a statement that doctors should think about restricting the use of acetaminophen, while also stating that "a proven link" between the medication and autism in children has not been established.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had promised in spring to conduct "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a matter of months.

But authorities cautioned that identifying a single cause of autism - thought by researchers to be the outcome of a complex mix of genetic and external influences - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that affects how people experience and engage with the world, and is recognized using physician assessments.

In his court filing, the attorney general - who supports Trump who is running for the Senate - asserts the manufacturer and J&J "intentionally overlooked and sought to suppress the research" around paracetamol and autism.

The case attempts to require the companies "remove any marketing or advertising" that asserts acetaminophen is safe for pregnant women.

The court case parallels the grievances of a collection of parents of young ones with autism spectrum disorder and ADHD who took legal action against the producers of acetaminophen in two years ago.

A federal judge rejected the lawsuit, stating investigations from the family's specialists was lacking definitive proof.